James Kasuboski

James Kasuboski is a distinguished professional in the field of molecular and cellular biology, currently serving as Partner and Head of Research at Luma Group since January 2024. In this role, James leads a team of diverse experts dedicated to advancing human health outcomes through strategic investments in scientific innovation. With extensive experience in advisory and board positions across various organizations, including the DR RALPH AND MARIAN FALK MEDICAL RESEARCH TRUST and Avilar Therapeutics, James contributes valuable insights as a grant reviewer for the National Cancer Institute and an advisor at the Chicago Biomedical Consortium. James holds a Ph.D. in Molecular & Cellular Biology from the University of Notre Dame and a B.S. in Biology from Hillsdale College.